DEN220041 is an FDA 510(k) submission (not cleared) for the Tristel Duo ULT. Classified as Foam Or Gel Chemical Sterilant/high Level Disinfectant (product code QWS), Class II - Special Controls.
Submitted by Tristel Solutions Limited (Snailwell, GB). The FDA issued a Not Cleared (DENG) decision on June 2, 2023 after a review of 338 days.
This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6886 - the FDA general hospital device framework. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.
Device pattern: Regulatory edge-case submission. High predicate equivalence gap. With 338 days under review and no clearance granted, this submission reflects a case where the FDA could not confirm sufficient predicate equivalence - often indicating either a novel device category or unresolved safety and performance questions.
View all Tristel Solutions Limited devices